Efficacy and Safety of Neoadjuvant Pyrotinib for Human Epidermal Receptor 2-Positive Breast Cancer: A Meta-Analysis

Tohoku J Exp Med. 2024 Apr 25. doi: 10.1620/tjem.2024.J026. Online ahead of print.NO ABSTRACTPMID:38658346 | DOI:10.1620/tjem.2024.J026

Source: The Tohoku Journal of Experimental Medicine - April 24, 2024 Category: Research Authors: Xiaona Lin Xiao Liu Xiaohui Yang Feng Sun Source Type: research